Foxp3+ regulatory T cells promote lung epithelial proliferation-Reference-Cited by-同舟云学术

Foxp3+ regulatory T cells promote lung epithelial proliferation

Published:2014-05-21 Issue:6 Volume:7 Page:1440-1451
ISSN:1933-0219
Container-title:Mucosal Immunology
language:en
Short-container-title:Mucosal Immunol

Author:

Mock J R,Garibaldi B T,Aggarwal N R,Jenkins J,Limjunyawong N,Singer B D,Chau E,Rabold R,Files D C,Sidhaye V,Mitzner W,Wagner E M,King L S,D'Alessio F R

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/mi201433.pdf

Reference56 articles.

1. Ware, L.B. & Matthay, M.A. The acute respiratory distress syndrome. N. Engl. J. Med. 342, 1334–1349 (2000).

2. Ranieri, V.M. et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 307, 2526–2533 (2012).

3. Brower, R.G. et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N. Engl. J. Med. 342, 1301–1308 (2000).

4. Guerin, C. et al. Prone positioning in severe acute respiratory distress syndrome. N. Engl. J. Med. 368, 2159–2168 (2013).

5. Mizgerd, J.P. Respiratory infection and the impact of pulmonary immunity on lung health and disease. Am. J. Respir. Crit. Care Med. 186, 824–829 (2012).

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem cells, cell therapies, and bioengineering in lung biology and diseases 2023;American Journal of Physiology-Lung Cellular and Molecular Physiology;2024-09-01

2. Low-dose interleukin-2 in patients with bipolar depression: A phase 2 randomised double-blind placebo-controlled trial;Brain, Behavior, and Immunity;2024-09

3. Contribution of Tregs to the promotion of constructive remodeling after decellularized extracellular matrix material implantation;Materials Today Bio;2024-08

4. Regulatory T Cells in Acute Respiratory Distress Syndrome: Current Status and Potential for Future Immunotherapies;Anesthesiology;2024-07-22

5. Low-dose interleukin-2 in patients with bipolar depression: a phase 2 randomised double-blind placebo-controlled trial;2024-07-19